Grant: Fellowship: Canada Impact+ Research Training Awards - Postdoctoral
McGill University
$140,000.00
Characterizing Senescence-Associated Pathways and Senolytic Responses in Adolescent Idiopathic Scoliosis
FY 2025-26
Summary
"Adolescent idiopathic scoliosis (AIS) is a complex spinal deformity associated with progressive curvature, pain, and reduced quality of life. Current treatment options are limited, in part due to an incomplete understanding of the biological mechanisms driving disease progression. Emerging evidence suggests that facet joint osteoarthritis (OA) contributes to curve progression in AIS, highlighting the need for disease-modifying therapeutic strategies.
Cellular senescence is a key driver of tissue degeneration through non-reversable cell-cycle arrest and adoption of a pro-inflammatory senescence-associated secretory phenotype (SASP). Recent studies demonstrate that senescence is a prominent feature of AIS-associated facet joint OA and correlates with OA severity. O-vanillin, a naturally derived compound with senolytic and senomorphic properties, has been shown to selectively eliminate senescent musculoskeletal cells and reduce SASP, however, its molecular targets and mechanisms of action in AIS remain poorly defined.
The aim of this project is to define how o-vanillin and optimized analogs modulate senescence-associated pathways in AIS. Using patient-derived chondrocytes and cartilage explant cultures, I will evaluate senolytic activity across a range of concentrations and dosing schedules by assessing cell viability, senescence markers (e.g., p16), and inflammatory gene expression. Transcriptomic profiling (RNA-seq) will be used to identify pathways associated with senolytic response and to distinguish effects in senescent versus non-senescent cells.
This work will establish a mechanistic framework for senolytic intervention in AIS and support the development of therapies targeting senescence-driven pathology.
"
Department
Program
Fellowship: Canada Impact+ Research Training Awards - Postdoctoral
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
568074
Name
Velez Julia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Postdoctoral
Projecttitle
Characterizing Senescence-Associated Pathways and Senolytic Responses in Adolescent Idiopathic Scoliosis
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Fellowship: Canada Impact+ Research Training Awards - Postdoctoral
Keyworddelim
Adolescent Idiopathic Scoliosis; Cellular Senescence; Chondrocytes; Disease-Modifying Therapy; Facet Joint Degeneration; Mechanism Of Action; Rna Sequencing; Senolytics
Abstract
"Adolescent idiopathic scoliosis (AIS) is a complex spinal deformity associated with progressive curvature, pain, and reduced quality of life. Current treatment options are limited, in part due to an incomplete understanding of the biological mechanisms driving disease progression. Emerging evidence suggests that facet joint osteoarthritis (OA) contributes to curve progression in AIS, highlighting the need for disease-modifying therapeutic strategies.
Cellular senescence is a key driver of tissue degeneration through non-reversable cell-cycle arrest and adoption of a pro-inflammatory senescence-associated secretory phenotype (SASP). Recent studies demonstrate that senescence is a prominent feature of AIS-associated facet joint OA and correlates with OA severity. O-vanillin, a naturally derived compound with senolytic and senomorphic properties, has been shown to selectively eliminate senescent musculoskeletal cells and reduce SASP, however, its molecular targets and mechanisms of action in AIS remain poorly defined.
The aim of this project is to define how o-vanillin and optimized analogs modulate senescence-associated pathways in AIS. Using patient-derived chondrocytes and cartilage explant cultures, I will evaluate senolytic activity across a range of concentrations and dosing schedules by assessing cell viability, senescence markers (e.g., p16), and inflammatory gene expression. Transcriptomic profiling (RNA-seq) will be used to identify pathways associated with senolytic response and to distinguish effects in senescent versus non-senescent cells.
This work will establish a mechanistic framework for senolytic intervention in AIS and support the development of therapies targeting senescence-driven pathology.
"
Competitiondate
202603
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Velez, Julia
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~